Cysteamine-induced depletion of somatostatin produces differential cognitive deficits in rats.
The effects of a variety of doses of systemically administered cysteamine (a somatostatin depletor) were studied on step-through passive avoidance retention, as well as acquisition and performance of a delayed spatial alternation task and a signaled extinction discrimination task in rats. Retention of single trial passive avoidance was significantly reduced by a pretraining (60-min) dose of cysteamine at 50, 100, 150 and 200 mg/kg s.c. This effect was shown to be sensitive to behavioral manipulation; in a second experiment, a retention deficit was found only at the two highest doses tested (150 and 200 mg/kg s.c.) after a second exposure to the footshock. In the operant conditioning studies, biweekly injections (Monday and Wednesday) of cysteamine administered one hour before testing produced no statistically significant changes in acquisition or performance of either the delayed spatial alternation or the signaled discrimination task. The results of these series of experiments suggest that active somatostatin release or chronic somatostatin depletion may selectively affect performance maintained by different behavioral procedures.
DeNoble
V J
VJ
E.I. duPont de Nemours & Co., Inc., Medical Products Department, Wilmington, DE 19880-0400.
Hepler
D J
DJ
Barto
R A
RA
D000818:Animals; D001362:Avoidance Learning / Q000502:physiology; D003072:Cognition Disorders / Q000139:chemically induced / Q000378:metabolism*; D003543:Cysteamine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013004:Somatostatin / Q000378:metabolism*; D013037:Spatial Behavior / Q000502:physiology
D013004:Somatostatin; D003543:Cysteamine